The Current State And Future Potential to Use Biomarkers In Schizophrenia Will Be Discussed In The Upcoming ECNS Conference

Schizophrenia is a debilitating disorder often characterized by structural and functional abnormalities in brain regions involved in cognitive, emotional and motivational aspects of behavior.
Currently, substantial efforts were devoted to identify potential biomarkers to diagnose and evaluate treatment response of the affected individuals. The current state and future potential to use biomarkers in schizophrenia will be discussed in the upcoming ECNS conference.

IMPORTANT DATES
May 27, 2016 - Symposium, Workshop, Course Proposals Deadline
June 24, 2016 - Abstract Submission Deadline
June 30, 2016 - End of Early Registration
July 01, 2016 - Preliminary Scientific Program